States have been slow to catch on, but some programs have proven to reapthe rewards
FDA Authorizes Novavax COVID-19 Vaccine
October 4th 2023It differs from the Pfizer and Moderna vaccine. Instead of using mRNA, the Novavax vaccines consists of proteins found in the spikes of the COVID-19 vaccine combined with an adjuvant made from the bark of a tree that grows in Chile.
Read More
Mostafa Kamal Talks Prime Therapeutics, Magellan Rx Integration, the Organization's Trajectory, More
September 13th 2023Managed Healthcare Executive's Managing Editor Peter Wehrwein, and Editor Briana Contreras, had a discussion in July with Mostafa Kamal, president and CEO of Prime Therapeutics, an organization in which Kamal acquired this position that same month.
Listen
Medicare’s Drug Negotiation Could Lead to Greater Access — or More Utilization Management
October 3rd 2023Even though the Inflation Reduction Act will require plans to justify formulary placement of negotiated drugs, payers have more of an incentive to steer patients to lower-cost alternatives.
Read More
In the Scope of Virtual Health and the Future of “Website” Manner, Per Ateev Mehrotra
August 10th 2023Briana Contreras, an editor of Managed Healthcare Executive, had the pleasure of catching up with MHE Editorial Advisory Board Member, Ateev Mehrotra, MD, MPH, who is a professor of healthcare policy at Harvard Medical School and an Associate Professor of Medicine and Hospitalist at Beth Israel Deaconess Medical Center.
Listen
Reduced Mortality Associated to Vitiligo
October 2nd 2023In a population-based cohort study, researchers explored the mortality of vitiligo as there is limited information about risks of mortality among these patients. The researchers investigated all-cause and cause-specific mortality of patients with vitiligo compared with controls without vitiligo using a nationwide database.
Read More
2 Clarke Drive
Cranbury, NJ 08512